Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).
Nieves Martinez-ChanzaLouisa SoukanePhilippe BarthelemyAurélien CarnotThierry GilVinciane CasertVincent VanhaudenardeBrieuc SautoisLionel StaudacherJan Van den BrandeStephane CulineEmmanuel SerontMarco GizziSimone AlbisinniThibault TricardJean Christophe FantoniMarianne PaesmansRafael CaparicaThierry RoumeguereAhmad AwadaPublished in: BMC cancer (2021)
ClinicalTrials.gov (NCT03674424).
Keyphrases
- phase ii study
- open label
- muscle invasive bladder cancer
- phase iii
- placebo controlled
- double blind
- phase ii
- locally advanced
- clinical trial
- squamous cell carcinoma
- study protocol
- rectal cancer
- small cell lung cancer
- lymph node
- high grade
- radiation therapy
- urinary tract
- cross sectional
- stem cells
- mesenchymal stem cells
- bone marrow